ESC Congress 2026 Abstract · Oct 26, 2026
Associations of cumulative exposure and change patterns of the normalised creatinine-to-cystatin C ratio with incident cardiovascular disease in CKM stage 0–3 adults: a CHARLS analysis
By Du B, He YQH, Wang XT et al.
Background: Creatinine-to-cystatin C ratio–derived indices have been linked to cardiovascular disease (CVD), yet most evidence relies on single time-point assessments. Whether cumulative exposure and pre-baseline change patterns of the normalised creatinine-to-cystatin C ratio (NCCR) inform CVD risk within cardiovascular–kidney–metabolic (CKM) stages 0–3 remains unclear. Purpose: To examine associations of cumulative NCCR burden (cumNCCR) and NCCR change patterns with incident CVD among adults with CKM stage 0–3. Methods: We analysed the China Health and Retirement Longitudinal Study (CHARLS; 2011–2020). Participants aged ≥45 years at the 2015 baseline, free of baseline CVD, with eGFR >30 mL/min/1.73 m², and classified as CKM stage 0–3 were included. NCCR was calculated as serum creatinine-to-cystatin C ratio normalised by body weight. CumNCCR from 2011 to 2015 was computed using a time-weighted trapezoidal area-under-the-curve approach and analysed per SD and tertiles. NCCR change patterns (2011–2015) were derived using k-medoids clustering. Incident CVD (heart disease and/or stroke) was ascertained at 2018/2020 follow-up interviews. Cox models adjusted for demographics, lifestyle factors, BMI, hypertension, diabetes, dyslipidaemia, and eGFR. Results: Among 3,222 participants, 635 incident CVD events occurred over 14,922 person-years (42.6 per 1,000 person-years). Higher cumNCCR was associated with lower CVD risk (per SD: HR 0.83, 95% CI 0.74–0.93; P=0.002); the highest versus lowest tertile showed reduced risk (HR 0.68, 0.53–0.87; P=0.002; P-trend=0.002). Baseline NCCR showed similar inverse associations. Compared with the low-stable pattern, the high level with increase pattern was associated with lower CVD risk (HR 0.72, 0.55–0.94; P=0.016). Restricted cubic splines supported a largely linear inverse dose–response (P for non-linearity=0.471). Conclusion: In adults with CKM stage 0–3, greater pre-baseline cumulative NCCR burden and favourable NCCR change patterns were associated with lower subsequent CVD risk, supporting time-integrated muscle-related biomarkers for upstream prevention risk stratification.NCCR indices and incident CVD in CKM0–3cumNCCR–CVD: spline, KM & subgroups